BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1589626)

  • 1. [Vincristine-induced recurrent laryngeal nerve paralysis].
    Núñez E; Solano D; Arreita A; Franco-Vicario R; Miguel F
    Rev Clin Esp; 1992 Mar; 190(4):214-5. PubMed ID: 1589626
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unilateral paralysis of the recurrent nerve caused by vincristine].
    Erdmann H
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():154-5. PubMed ID: 2342441
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vocal cord paralysis secondary to vincristine].
    Nafil H; Tazi I; Mahmal L
    Rev Neurol (Paris); 2012 May; 168(5):464-5. PubMed ID: 22387202
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral recurrent laryngeal nerve palsy resulting from treatment with vincristine.
    Harris CM; Blanchaert RH
    J Oral Maxillofac Surg; 2006 Apr; 64(4):738-9. PubMed ID: 16546662
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose vincristine-associated bilateral vocal cord paralysis.
    Ryan SP; DelPrete SA; Weinstein PW; Erichson RB; Bar MH; Lo KM; Cohen NS; Tepler I
    Conn Med; 1999 Oct; 63(10):583-4. PubMed ID: 10578547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose vincristine-associated bilateral vocal cord paralysis.
    Alfredsunder P; Hochman MC; Kaplan BH
    N Y State J Med; 1992 Jun; 92(6):268-9. PubMed ID: 1641212
    [No Abstract]   [Full Text] [Related]  

  • 9. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
    Al-Tourah AJ; Tsang PW; Skinnider BF; Hoskins PJ
    J Clin Oncol; 2006 May; 24(15):2388-9. PubMed ID: 16710039
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recurrent laryngeal nerve palsy and dysphagia for liquids due to vincristine].
    Manelis G; Aderka D; Manelis J; Horn I
    Harefuah; 1976 Aug; 91(3-4):84-5. PubMed ID: 976843
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilateral vocal fold paralysis following treatment with vincristine.
    Praveen CV; De Lord CF
    J Laryngol Otol; 2006 May; 120(5):423. PubMed ID: 16696885
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
    Zeidman A; Yarmolovsky A; Djaldetti M; Mittelman M
    Haematologia (Budap); 1995; 26(3):173-5. PubMed ID: 7797147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 16. Vincristine-induced recurrent laryngeal nerve paralysis.
    Annino DJ; MacArthur CJ; Friedman EM
    Laryngoscope; 1992 Nov; 102(11):1260-2. PubMed ID: 1405987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolymphocytic leukemia: diagnosis and treatment. A case report.
    Akin C; Hansen P; Janckila A
    J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.
    Padate BP; Keidan J
    Clin Lab Haematol; 2006 Feb; 28(1):69-71. PubMed ID: 16430465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of the pilot treatment of 9 patients with chronic lymphocytic leukemia or CLL lymphoplasmacytoid lymphoma by the CHOP protocol].
    Roliński J; Rupniewska ZM; Kowalewski J; Kowal M; Wach M
    Acta Haematol Pol; 1990; 21(2):185-91. PubMed ID: 2131718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.